03Jun 2024

UGI USER
antibody development epidemic preparedness IAV research infectious diseases medical research Nipah diagnostics Nipah virus public health innovation vaccine research India virus-like particles
62
0

IAV DEVELOPS NEW METHOD FOR NIPAH ANTIBODIES WITH VIRUS-LIKE PARTICLES

Why in the news? Scientists at the Institute of Advanced Virology (IAV) in Thonnakkal developed a method for producing non-infectious Nipah virus-like particles (VLPs) in the lab. These VLPs mimic the wild-type Nipah Virus (NiV), offering a safe and effective platform for developing neutralizing antibodies against NiV in a biosafety level-2 (BSL) laboratory. source:medium About …

26May 2024

UGI USER
clinical trial design Covaxin data Covaxin safety Health Policy India public health research methodology vaccine evaluation vaccine research India vaccine study criticism
56
0

“STUDY ON COVAXIN’S SAFETY CRITICIZED FOR POOR DESIGN”

Syllabus: GS-3- Advancement in the field of science and technology , Issues related to Vaccine safety and solutions needed Focus : The focus of the article is on the criticism faced by a study from Banaras Hindu University on Covaxin’s long-term safety. The study, published in the journal Drug Safety, was critiqued by ICMR and …

Tag

IAV DEVELOPS NEW METHOD FOR NIPAH ANTIBODIES WITH VIRUS-LIKE PARTICLES

“STUDY ON COVAXIN’S SAFETY CRITICIZED FOR POOR DESIGN”

FREE Career Guidance Program Online | Silver Jubilee Celebration 2026